502 related articles for article (PubMed ID: 22241171)
41. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
Cheng B; Yang X; An L; Gao B; Liu X
Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
[TBL] [Abstract][Full Text] [Related]
42. Charge Type, Charge Spacing, and Hydrophobicity of Arginine-Rich Cell-Penetrating Peptides Dictate Gene Transfection.
Alhakamy NA; Dhar P; Berkland CJ
Mol Pharm; 2016 Mar; 13(3):1047-57. PubMed ID: 26878305
[TBL] [Abstract][Full Text] [Related]
43. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
Juliano RL; Alam R; Dixit V; Kang HM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):324-35. PubMed ID: 20049800
[TBL] [Abstract][Full Text] [Related]
44. Intracellular trafficking of superparamagnetic iron oxide nanoparticles conjugated with TAT peptide: 3-dimensional electron tomography analysis.
Nair BG; Fukuda T; Mizuki T; Hanajiri T; Maekawa T
Biochem Biophys Res Commun; 2012 May; 421(4):763-7. PubMed ID: 22546557
[TBL] [Abstract][Full Text] [Related]
45. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
46. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU.
Subbarayan PR; Lee K; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422
[TBL] [Abstract][Full Text] [Related]
47. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells.
Rejinold NS; Han Y; Yoo J; Seok HY; Park JH; Kim YC
Sci Rep; 2018 Jan; 8(1):1899. PubMed ID: 29382898
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic applications of the cell-penetrating HIV-1 Tat peptide.
Rizzuti M; Nizzardo M; Zanetta C; Ramirez A; Corti S
Drug Discov Today; 2015 Jan; 20(1):76-85. PubMed ID: 25277319
[TBL] [Abstract][Full Text] [Related]
50. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
Yeh KY; Chang JW; Li YY; Wang CH; Wang HM
Head Neck; 2011 May; 33(5):734-42. PubMed ID: 20737493
[TBL] [Abstract][Full Text] [Related]
51. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
52. Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo.
Nakase I; Konishi Y; Ueda M; Saji H; Futaki S
J Control Release; 2012 Apr; 159(2):181-8. PubMed ID: 22285548
[TBL] [Abstract][Full Text] [Related]
53. A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
Ahn RW; Chen F; Chen H; Stern ST; Clogston JD; Patri AK; Raja MR; Swindell EP; Parimi V; Cryns VL; O'Halloran TV
Clin Cancer Res; 2010 Jul; 16(14):3607-17. PubMed ID: 20519360
[TBL] [Abstract][Full Text] [Related]
54. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
Zhang Q; Gao H; He Q
Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
[TBL] [Abstract][Full Text] [Related]
55. Effects of Tat peptide on intracellular delivery of arsenic trioxide albumin microspheres.
Zhou J; Wang QH; Liu JH; Wan YB
Anticancer Drugs; 2012 Mar; 23(3):303-12. PubMed ID: 22123336
[TBL] [Abstract][Full Text] [Related]
56. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
57. Design of a tumor-homing cell-penetrating peptide.
Myrberg H; Zhang L; Mäe M; Langel U
Bioconjug Chem; 2008 Jan; 19(1):70-5. PubMed ID: 18001077
[TBL] [Abstract][Full Text] [Related]
58. Arsenic trioxide.
Wilkinson K
Clin J Oncol Nurs; 2001; 5(5):237-8. PubMed ID: 11899773
[No Abstract] [Full Text] [Related]
59. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
60. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency.
Rahmat D; Khan MI; Shahnaz G; Sakloetsakun D; Perera G; Bernkop-Schnürch A
Biomaterials; 2012 Mar; 33(7):2321-6. PubMed ID: 22169137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
